kabutan

RIKEN TECHNOS CORPORATION(4220) Summary

4220
TSE Prime
RIKEN TECHNOS CORPORATION
1,676
JPY
+42
(+2.57%)
Apr 28, 3:30 pm JST
10.52
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
11.0
PBR
1.25
Yield
3.10%
Margin Trading Ratio
3.22
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,650 JPY 10.35 USD
Previous Close Apr 27
1,634 JPY 10.25 USD
High Apr 28, 3:30 pm
1,676 JPY 10.52 USD
Low Apr 28, 9:13 am
1,639 JPY 10.28 USD
Volume
98,300
Trading Value
0.16B JPY 1.03M USD
VWAP
1665.97 JPY 10.46 USD
Minimum Trading Value
167,600 JPY 1,052 USD
Market Cap
0.09T JPY 0.54B USD
Number of Trades
251
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Mid
1-Year Average
339
1-Year High Jan 30, 2026
1,907
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 26,800 45,700 1.71
Apr 17, 2026 26,800 41,800 1.56
Apr 10, 2026 17,800 42,000 2.36
Apr 3, 2026 19,600 52,100 2.66
Mar 27, 2026 224,600 52,900 0.24
Company Profile
RIKEN TECHNOS CORPORATION is a leading manufacturer of PVC compounds. The company also has a strong presence in decorative films, with its highly transparent films featuring antibacterial properties.
Sector
Chemicals
RIKEN TECHNOS CORPORATION specializes in synthetic resin processing, manufacturing and selling compounds, films, and food packaging materials. The company's operations are divided into four market-based segments, covering Transportation (including automotive, railway, and marine), Daily Life & Healthcare, Electronics, and Building & Construction. RIKEN TECHNOS CORPORATION provides products for a wide range of industries, including functional parts for automobiles, medical and healthcare products, cable materials for information infrastructure, and construction materials. With numerous subsidiaries both domestically and internationally, the company operates on a global scale. RIKEN TECHNOS CORPORATION is particularly focused on establishing a strong presence in the Asian and North American automotive markets, while also concentrating on expanding its high-value-added products in the medical field.